UK markets closed

IGC Pharma, Inc. (IGC)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
0.5298+0.0098 (+1.88%)
As of 12:02PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
1,216
911
397
898
Cost of revenue
591
469
203
785
Gross profit
625
442
194
113
Operating expenses
Research development
3,411
3,461
2,330
929
Selling general and administrative
8,881
8,552
13,292
7,908
Total operating expenses
12,292
12,013
15,622
8,837
Operating income or loss
-11,667
-11,571
-15,428
-8,724
Total other income/expenses net
-2,478
65
412
-87
Income before tax
-14,145
-11,506
-15,016
-8,811
Income tax expense
0
0
0
0
Income from continuing operations
-14,145
-11,506
-15,016
-8,811
Net income
-14,145
-11,506
-15,016
-8,811
Net income available to common shareholders
-14,145
-11,506
-15,016
-8,811
Basic EPS
-0.20
-0.22
-0.30
-0.21
Diluted EPS
-0.20
-0.22
-0.30
-0.21
Basic average shares
53,383
52,576
49,992
41,963
Diluted average shares
53,383
52,576
49,992
41,963